ELCEPAN

Main information

  • Trade name:
  • ELCEPAN 10 TAB
  • Dosage:
  • 50,200;MG
  • Pharmaceutical form:
  • TAB
  • Composition:
  • 10
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ELCEPAN 10 TAB
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

3-8-2017

FDA Drug Safety Communication: Ongoing Safety Review of Stalevo (entacapone/carbidopa/levodopa) and possible development of Prostate Cancer

FDA Drug Safety Communication: Ongoing Safety Review of Stalevo (entacapone/carbidopa/levodopa) and possible development of Prostate Cancer

[03-31-2010] The U.S. Food and Drug Administration (FDA) is evaluating clinical trial data that may suggest that patients taking Stalevo, a Parkinson's disease medication, may be at an increased risk for developing prostate cancer.

FDA - U.S. Food and Drug Administration

19-4-2018

Sinemet vs. Parcopa

Sinemet vs. Parcopa

Sinemet (carbidopa-levodopa) and Parcopa (carbidopa and levodopa) are combinations of an inhibitor of aromatic amino acid decarboxylation and an aromatic amino acid used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control. Sinemet and Parcopa are also used to treat Parkinson symptoms caused by carbon monoxide poisoning or manganese intoxication.

US - RxList

19-4-2018

Sinemet vs. Requip

Sinemet vs. Requip

Sinemet (carbidopa-levodopa) and Requip (ropinirole) are used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control. Sinemet is also used to treat Parkinson symptoms caused by carbon monoxide poisoning or manganese intoxication. Requip is also used to treat restless legs syndrome (RLS).

US - RxList

19-4-2018

Sinemet vs. Rytary

Sinemet vs. Rytary

Sinemet (carbidopa-levodopa) and Rytary (carbidopa and levodopa) are combinations of an inhibitor of aromatic amino acid decarboxylation and an aromatic amino acid used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control. Sinemet and Rytary are also used to treat Parkinson symptoms caused by carbon monoxide poisoning or manganese intoxication.

US - RxList

19-4-2018

Sinemet vs. Stalevo

Sinemet vs. Stalevo

Sinemet (carbidopa-levodopa) and Stalevo (carbidopa, levodopa, and entacapone) are combination drugs used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control. Sinemet is also used to treat Parkinson symptoms caused by carbon monoxide poisoning or manganese intoxication.

US - RxList

4-4-2018

CARBIDOPA AND LEVODOPA Tablet [Preferred Pharmaceuticals, Inc.]

CARBIDOPA AND LEVODOPA Tablet [Preferred Pharmaceuticals, Inc.]

Updated Date: Apr 4, 2018 EST

US - DailyMed

27-12-2017

CARBIDOPA AND LEVODOPA Tablet [Carilion Materials Management]

CARBIDOPA AND LEVODOPA Tablet [Carilion Materials Management]

Updated Date: Dec 27, 2017 EST

US - DailyMed

21-12-2017

CARBIDOPA AND LEVODOPA Tablet [Mayne Pharma Inc.]

CARBIDOPA AND LEVODOPA Tablet [Mayne Pharma Inc.]

Updated Date: Dec 21, 2017 EST

US - DailyMed

14-12-2017

DUOPA (Carbidopa And Levodopa) Suspension [AbbVie Inc.]

DUOPA (Carbidopa And Levodopa) Suspension [AbbVie Inc.]

Updated Date: Dec 14, 2017 EST

US - DailyMed

11-12-2017

CARBIDOPA AND LEVODOPA Tablet [Actavis Pharma, Inc.]

CARBIDOPA AND LEVODOPA Tablet [Actavis Pharma, Inc.]

Updated Date: Dec 11, 2017 EST

US - DailyMed

7-11-2017

Carbidopa/Levodopa

Carbidopa/Levodopa

Carbidopa/levodopa is a combination of an inhibitor of aromatic amino acid decarboxylation and an aromatic amino acid used to treat Parkinson symptoms such as muscle stiffness, tremors, spasms, and poor muscle control.

US - RxList

18-10-2017

CARBIDOPA AND LEVODOPA Tablet [Aphena Pharma Solutions - Tennessee, LLC]

CARBIDOPA AND LEVODOPA Tablet [Aphena Pharma Solutions - Tennessee, LLC]

Updated Date: Oct 18, 2017 EST

US - DailyMed

18-10-2017

CARBIDOPA AND LEVODOPA Tablet [Golden State Medical Supply, Inc.]

CARBIDOPA AND LEVODOPA Tablet [Golden State Medical Supply, Inc.]

Updated Date: Oct 18, 2017 EST

US - DailyMed

6-10-2017

CARBIDOPA AND LEVODOPA Tablet [American Health Packaging]

CARBIDOPA AND LEVODOPA Tablet [American Health Packaging]

Updated Date: Oct 6, 2017 EST

US - DailyMed

1-9-2017

CARBIDOPA AND LEVODOPA Tablet, Extended Release [American Health Packaging]

CARBIDOPA AND LEVODOPA Tablet, Extended Release [American Health Packaging]

Updated Date: Sep 1, 2017 EST

US - DailyMed

29-8-2017

CARBIDOPA AND LEVODOPA Tablet [NuCare Pharmaceuticals,Inc.]

CARBIDOPA AND LEVODOPA Tablet [NuCare Pharmaceuticals,Inc.]

Updated Date: Aug 29, 2017 EST

US - DailyMed

25-8-2017

FDA Clears First Drug for Parkinson's Dyskinesia

FDA Clears First Drug for Parkinson's Dyskinesia

The US Food and Drug Administration (FDA) has approved amantadine extended-release capsules (Gocovri, Adamas Pharmaceuticals Inc) for treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications, the company announced today.

US - RxList

31-7-2017

CARBIDOPA AND LEVODOPA Tablet, Orally Disintegrating [Sun Pharma Global FZE]

CARBIDOPA AND LEVODOPA Tablet, Orally Disintegrating [Sun Pharma Global FZE]

Updated Date: Jul 31, 2017 EST

US - DailyMed

31-7-2017

CARBIDOPA AND LEVODOPA Tablet [Sun Pharmaceutical Industries Limited ]

CARBIDOPA AND LEVODOPA Tablet [Sun Pharmaceutical Industries Limited ]

Updated Date: Jul 31, 2017 EST

US - DailyMed

18-7-2017

CARBIDOPA AND LEVODOPA Tablet [Unit Dose Services]

CARBIDOPA AND LEVODOPA Tablet [Unit Dose Services]

Updated Date: Jul 18, 2017 EST

US - DailyMed

28-6-2017

CARBIDOPA AND LEVODOPA Tablet [McKesson Corporation]

CARBIDOPA AND LEVODOPA Tablet [McKesson Corporation]

Updated Date: Jun 28, 2017 EST

US - DailyMed

22-6-2017

CARBIDOPA AND LEVODOPA Tablet [Bryant Ranch Prepack]

CARBIDOPA AND LEVODOPA Tablet [Bryant Ranch Prepack]

Updated Date: Jun 22, 2017 EST

US - DailyMed